Wanbury Investor Presentation on Q2 & H1FY26 Financial Results
Wanbury Limited announced its investor presentation on Q2 & H1FY26 financial results, highlighting EBITDA growth, reduced borrowing costs, and a focus on regulated markets and new molecule launches.
The positive financial results and strategic initiatives suggest a moderate positive impact on the company's performance and future prospects.
The announcement highlights positive financial performance, including EBITDA growth and reduced borrowing costs, along with strategic initiatives for future growth.
* Wanbury Limited has announced its investor presentation on the financial results for Q2 & H1FY26. * The company achieved its highest-ever operational EBITDA of ₹80 crore. * The company's borrowing costs have been reduced from 22.5% to 12.5% effective from 1st March 2025. * The company is focused on regulated markets for API business, including the US, EU, and Brazil. * The company aims for commercial launches of 4 new molecules each year beginning FY27. * The company's formulation business turned EBITDA positive with the launch of a new brand (C-red). * Q2FY26 EBITDA stood at ₹26.0 crore with a margin of 16.2% and PAT at ₹15.2 crore. * The company aims to achieve profitability break-even in FY26 through better scale & cost-management efforts in formulations business. * Management Commentary: Q2 continues to be stronger with EBITDA achievement of ₹ 26.0 crore as compared to ₹21.6 crore in Q2 FY25, registering a growth of 20% over previous quarter, overall improvement of 292 bps of revenues. Further, achieved PAT of ₹ 15.2 crore as compared to ₹ 8.0 crore in Q2 FY25, registering a robust growth of approx. 90 % led by cost efficiencies, improved Product yield & lower finance cost.
What to do with a filing like this
Wanbury Limited filed this with the NSE as a statutory disclosure, categorised under investor presentation. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Wanbury Limited. Read the original for the full detail.